Symbiotec to Build Dedicated Precision Fermentation Plant in India for European Alt Protein Client
Vegconomist • Nov 16, 2026
Symbiotec Pharmalab, an Indian manufacturer, has entered into a 10-year contract with a prominent European alternative protein company to produce fermentation-based protein at its biomanufacturing facility in Ujjain, Madhya Pradesh. This deal, announced on November 6, ensures reserved capacity at the plant, with a take-or-pay structure that guarantees payment regardless of usage. While the specifics of the protein type, contract value, and partner identity remain undisclosed, the partnership marks a significant step towards more sustainable food production.
Production will commence using existing facilities with large-scale fermenters, followed by the construction of a dedicated plant for the partner, expected to have capacities reaching millions of liters. Symbiotec aims to meet stringent quality standards typical of the pharmaceutical industry in its food protein production, emphasizing the need for cost-effective, high-quality alternatives. The company anticipates initial manufacturing to begin by early 2027 and is optimistic about serving various sectors, including nutrition and industrial bioproducts, as part of a broader push for greener production methods.